alovudine has been researched along with Cancer of Head in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (20.83) | 29.6817 |
2010's | 18 (75.00) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
Bak, B; Cegła, P; Cholewinski, W; Kazmierska, J; Malicki, J; Piotrowski, T; Sowinska, A | 1 |
Cegla, P; Joanna, K; Julian, M; Michal, S; Sebastian, G; Witold, C | 1 |
Fatema, CN; Kitagawa, Y; Kuge, Y; Murakami, M; Nishijima, K; Tamaki, N; Yu, W; Zhao, S; Zhao, Y | 1 |
Hoshikawa, H; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y | 1 |
Buatti, JM; Menda, Y | 1 |
Arens, AI; Bussink, J; Grégoire, V; Grootjans, W; Hatt, M; Hoeben, BA; Kaanders, JH; Lee, JA; Oyen, WJ; Troost, EG; Visser, EP; Visvikis, D | 1 |
Bussink, J; Hoeben, BA; Kaanders, JH; Oyen, WJ; Troost, EG; van Herpen, CM | 1 |
Chalkidou, A; Fenwick, JD; Landau, DB; Liu, D; Marsden, PK | 1 |
Bai, GH; Cabrera, AR; Lee, J; Li, YH; Liu, J; Sun, XD; Yang, J; Yu, JM; Yue, JB | 1 |
Fukumura, T; Hoshikawa, H; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Samukawa, Y; Yamamoto, Y | 2 |
Boellaard, R; de Bree, R; de Langen, AJ; Hoekstra, OS; Klabbers, B; Lammertsma, AA; Lubberink, M; Slotman, BJ; Smit, EF; Spreeuwenberg, MD | 1 |
Boles Ponto, LL; Buatti, JM; Dornfeld, KJ; Graham, MM; Menda, Y; Schultz, MK; Sunderland, JJ; Tewson, TJ; Watkins, GL | 1 |
Buck, AK; Fayad, L; Graham, MM; Herrmann, K; Juweid, ME; Menda, Y; Tewson, T; Thomas, D | 1 |
Anderson, C; Buatti, JM; Dornfeld, KJ; Graham, MM; Gupta, AK; McGuire, S; Menda, Y; Ponto, LL; Schultz, MK; Sunderland, JJ; Tewson, TJ; Watkins, GL | 1 |
Boles Ponto, LL; Buatti, J; Dornfeld, K; Graham, MM; Menda, Y; Sunderland, J; Tewson, TJ; Watkins, GL | 1 |
Bayouth, JE; Boles Ponto, LL; Buatti, J; Gross, B; McGuire, SM; Menda, Y | 1 |
Hoshikawa, H; Kishino, T; Mori, N; Nishiyama, Y; Yamamoto, Y | 1 |
Fukumura, T; Hasegawa, A; Inubushi, M; Kamada, T; Koizumi, M; Koto, M; Morikawa, T; Saga, T; Takagi, R; Tanimoto, K; Wakatuki, M; Yamada, S; Yoshikawa, K | 1 |
Bussink, J; Hoeben, BA; Kaanders, JH; Oyen, WJ; Span, PN; Troost, EG; van Herpen, CM | 1 |
Akiyama, K; Hoshikawa, H; Inamoto, R; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y | 1 |
Bussink, J; Kaanders, JH; Marres, HA; Merkx, MA; Oyen, WJ; Peeters, WJ; Slootweg, PJ; Troost, EG; van der Kogel, AJ; Vogel, WV | 1 |
Atkinson, DM; Carlson, BL; Clarke, MJ; Jacobson, MS; Kemp, BJ; Lowe, VJ; Mladek, AC; Sarkaria, JN; Trump, DP | 1 |
Angelberger, P; Becherer, A; Dudczak, R; Ewers, R; Kermer, C; Kletter, K; Linecker, A; Sulzbacher, I | 1 |
7 trial(s) available for alovudine and Cancer of Head
Article | Year |
---|---|
Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy.
Topics: Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Computer Simulation; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant | 2009 |
Investigation of the pharmacokinetics of 3'-deoxy-3'-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer.
Topics: Bone Marrow; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Time Factors | 2010 |
Stability of 3'-deoxy-3'-[18F]fluorothymidine standardized uptake values in head and neck cancer over time.
Topics: Aged; Carboplatin; Cisplatin; Dideoxynucleosides; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2010 |
Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Female; Follow-Up Studies; Head and Neck Neoplasms; Heavy Ion Radiotherapy; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome.
Topics: Adult; Aged; Biological Transport; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Time Factors; Treatment Outcome | 2013 |
Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Pseudolymphoma; Radiopharmaceuticals; Treatment Outcome | 2007 |
17 other study(ies) available for alovudine and Cancer of Head
Article | Year |
---|---|
Assessment of tumour hypoxia, proliferation and glucose metabolism in head and neck cancer before and during treatment.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Chemoradiotherapy; Cisplatin; Dideoxynucleosides; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Misonidazole; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation-Sensitizing Agents; Treatment Outcome; Tumor Hypoxia | 2020 |
Correlation between tumour biology status measured in triple-tracer 18F-fluorodeoxyglucose-18F-fluorothymidine- 18F-fluoromisonidazole-PET/CT study and human papillomavirus status in patients with head and neck cancer.
Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Misonidazole; Papillomaviridae; Positron Emission Tomography Computed Tomography; Radioactive Tracers | 2019 |
Monitoring tumor proliferative response to radiotherapy using (18)F-fluorothymidine in human head and neck cancer xenograft in comparison with Ki-67.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Dideoxynucleosides; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
The value of 18F-FLT PET for detecting second primary cancers and distant metastases in head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
PET imaging during radiotherapy of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Positron-Emission Tomography | 2013 |
Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2014 |
18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
18F-FLT uptake kinetics in head and neck squamous cell carcinoma: a PET imaging study.
Topics: Biological Transport; Carcinoma, Squamous Cell; Cell Proliferation; Dideoxynucleosides; Head and Neck Neoplasms; Humans; Kinetics; Models, Biological; Positron-Emission Tomography | 2014 |
Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
Topics: Animals; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Dideoxynucleosides; Dose Fractionation, Radiation; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2014 |
Predictive value of SUV-based parameters derived from pre-treatment (18)F-FLT PET/CT for short-term outcome with head and neck cancers.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results | 2009 |
PET/CT with 18F-FLT is unlikely to cause significant hepatorenal or hematologic toxicity.
Topics: Dideoxynucleosides; Head and Neck Neoplasms; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Lymphoma; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Tomography, Emission-Computed | 2010 |
3'-deoxy-3'-[¹⁸F]fluorothymidine PET quantification of bone marrow response to radiation dose.
Topics: Bone Marrow; Bone Marrow Cells; Cell Proliferation; Dideoxynucleosides; Dose-Response Relationship, Radiation; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
Usefulness of 3'-deoxy-3'-18F-fluorothymidine PET for predicting early response to chemoradiotherapy in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Dideoxynucleosides; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines | 2008 |
Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival.
Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radioisotopes; Survival Analysis | 2008 |